More Multinational Drug Firms Conducting Clinical Trials In Japan
This article was originally published in PharmAsia News
Japan is drawing an increasing number of multinational drug companies in terms of clinical trials on their products
You may also be interested in...
After a tepid performance in the fiscal fourth quarter, Torrent expects its key markets India, US and Brazil to be impacted the COVID-19 fallout as well as a lack of visibility on regulatory approvals for its manufacturing facilities.
Biotronik recently hired its first-ever chief medical officer, former Mayo Clinic medical director David Hayes, as part of a bid to deepen the Berlin-based firm’s relationships in the US. Here’s what company president Ryan Walters said about the American market.
The pharmaceutical selling model will be modified even after the immediate COVID-19 pandemic crisis abates, the consulting firm ZS Associates predicts, citing new research.